Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies
about
Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignImpact of lipids and lipoproteins on hepatitis C virus infection and virus neutralizationThe hepatitis C virus glycan shield and evasion of the humoral immune responseHepatitis C Virus entry: the early steps in the viral replication cycleApolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptorCS-SELEX Generates High-Affinity ssDNA Aptamers as Molecular Probes for Hepatitis C Virus Envelope Glycoprotein E2Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agentsNaturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralizationHepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell cultureDifferent requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmissionFunctional selection of hepatitis C virus envelope E2-binding Peptide ligands by using ribosome displayAdaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors.Nonstructural protein 5A is incorporated into hepatitis C virus low-density particle through interaction with core protein and microtubules during intracellular transport.Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies.Modulation of triglyceride and cholesterol ester synthesis impairs assembly of infectious hepatitis C virus.Structural basis for broad neutralization of hepatitis C virus quasispecies.Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantationThe rate of hepatitis C virus infection initiation in vitro is directly related to particle density.Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors.Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agentsThe Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.Interplay between basic residues of hepatitis C virus glycoprotein E2 with viral receptors, neutralizing antibodies and lipoproteins.Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralizationHepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not neutralization serotype.Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry.Adaptive immunity to hepatitis C virus.Production and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1-6.A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo.Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals.Hepatitis C virus infection of neuroepithelioma cell lines.Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant.New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I.Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A.Broadly neutralizing immune responses against hepatitis C virus induced by vectored measles viruses and a recombinant envelope protein boosterNeutralizing antibodies and pathogenesis of hepatitis C virus infection.Disulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein.Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus
P2860
Q26801759-EF8AC916-C781-4A3C-968B-C8000580CDE5Q26864485-F91EAC24-53B1-468A-A553-064348647C0AQ27023390-EF14EF04-C6FC-43FE-9224-7C03FAED91EFQ27489242-49070C78-1F95-44BD-BE03-4ABA9065582BQ27490234-C94E6244-CD9F-41BA-87F0-888A7F15D36AQ27490421-B800BF91-C739-4B2B-8F97-5DA79665E337Q28538891-78B76987-A135-41C1-9F25-0F18D57A16FAQ28731355-CC0D4AA5-4528-499F-9239-C50EBBBA209AQ30386551-C6E0ACB6-77A5-40EB-A65F-3A553288ECA1Q30432551-1064A42B-9B51-47DD-9756-E7B7AF1904F6Q30541733-0DA1506C-5424-4237-A2A4-8F337D050293Q33579851-17C7BE5A-2B3B-4959-93C5-D20AF637C879Q33628805-09636F12-54E9-48F3-96F2-20665927786DQ33721523-D29502ED-D76F-4F29-BFB1-C97DA2A9A4BDQ33877381-0A26655A-2EAA-49F9-9C6D-93B121B1B18FQ33985223-5B0C57C4-7710-496A-A319-DE14930CC124Q34064882-F4E0ABC2-6A9F-43C7-8EF1-D1B0FD15D459Q34096483-690AD391-1718-4F25-8070-E99BEAB40598Q34158687-E1B33DE4-9F51-4D27-B339-67E518CA39A1Q34262175-0A4EA34E-1C70-4798-9567-0CC22EC77129Q34416004-91548517-1103-4E9B-800B-2C008DC36290Q34481429-34D58047-6DC6-4A49-9288-DAB5909A524CQ34540988-4013AE4C-6132-47F3-A1EC-C568AAB96F26Q34741652-219167DE-766E-4D77-8A3A-5C0255FE0564Q35076885-5DB7636D-6045-4560-B32C-018671F55514Q35213305-A46EEB72-D020-4B9F-8588-CCF96471A103Q35259748-AB66341D-46FB-4F5B-A745-62F71AA1622AQ35557533-CCF9B90F-9D5A-485B-902D-98BEE5CCE20FQ35685409-F7730728-BEF4-4B5E-B829-31C81927514CQ35694689-1D867AC7-36E2-480A-B21E-740AE4F2AC8FQ35818245-BC369231-711F-4B84-AFF8-90490F87B3AEQ35861270-2017DB3A-EDA4-422B-8D06-4414AD6D8E22Q35914270-7400C9CB-CE0B-4321-88E6-449A8EEF66A1Q36133495-2685EC8A-6A60-41E1-839B-3CC45397AA6BQ36288404-6D79D4FF-3096-4D78-A4CE-97CBEF69BB7DQ36363203-FD9F94C9-A074-45CD-8197-FAF03665F634Q36395837-8B505984-CEBD-494C-92C2-2B45B2582F8BQ36559948-3E31C330-EE2B-4158-A04B-A85E32995BA7Q37015738-15561A03-56AF-4004-8545-0359F9DC30CAQ37547255-90193698-A980-45CE-87BF-B6B1EE1C218A
P2860
Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Identification of a Residue in ...... ity to Neutralizing Antibodies
@ast
Identification of a Residue in ...... ity to Neutralizing Antibodies
@en
Identification of a Residue in ...... ity to Neutralizing Antibodies
@nl
type
label
Identification of a Residue in ...... ity to Neutralizing Antibodies
@ast
Identification of a Residue in ...... ity to Neutralizing Antibodies
@en
Identification of a Residue in ...... ity to Neutralizing Antibodies
@nl
prefLabel
Identification of a Residue in ...... ity to Neutralizing Antibodies
@ast
Identification of a Residue in ...... ity to Neutralizing Antibodies
@en
Identification of a Residue in ...... ity to Neutralizing Antibodies
@nl
P2093
P2860
P50
P356
P1433
P1476
Identification of a Residue in ...... ity to Neutralizing Antibodies
@en
P2093
Margaret F Bassendine
Søren Nielsen
P2860
P304
P356
10.1128/JVI.01569-08
P577
2008-12-01T00:00:00Z